Structure Therapeutics Inc. is seeking a Director of Analytical Development to lead analytical development activities supporting late‑stage development, Phase 3 programs, PPQ, commercialization, and global regulatory filings.
This role requires deep expertise in small‑molecule analytical sciences, regulatory expectations for global submissions, and cross‑functional CMC strategy to support late-stage clinical starts and regulatory inspections.
#J-18808-LjbffrHead of Analytical Development — Late-Stage & Submissions in south san francisco at Unknown Company
This position is listed as full time and onsite.